Evidence map›Paper›PMID 25494299›Full record

ReviewAnnual review of biochemistry2015

Biochemical Properties and Biological Functions of FET Proteins.

Jacob C Schwartz, Thomas R Cech, Roy R Parker

Open access · bronzeAbstract readReview
In one paragraph

Review in Annual review of biochemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 156 papers.

0numbers the graph read from it
0cells of the map it votes in
156citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

156 citing papers in PubMed, 229 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

96 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Jacob C SchwartzHoward Hughes Medical Institute, Department of Chemistry and Biochemistry, and BioFrontiers Institute, University of Colorado, Boulder, Colorado 80309; email: jcschwartz@email.arizona.edu , thomas.cech@colorado.edu , roy.parker@colorado.edu.
Thomas R Cech
Roy R Parker
University of Colorado Boulder · USHoward Hughes Medical Institute · US

Funding

Analysis of the RNA-binding Protein FUS and Its Role in Neurodegenerative DiseaseK99NS082376 · NINDS · UNIVERSITY OF COLORADO · PI SCHWARTZ, JACOB C. · 2013 to 2014
$192k
Howard Hughes Medical InstituteNINDS NIH HHS 1K99NS082376-01A1NINDS NIH HHS K99 NS082376
6 · The paper itself

Abstract

Members of the FET protein family, consisting of FUS, EWSR1, and TAF15, bind to RNA and contribute to the control of transcription, RNA processing, and the cytoplasmic fates of messenger RNAs in metazoa. FET proteins can also bind DNA, which may be important in transcription and DNA damage responses. FET proteins are of medical interest because chromosomal rearrangements of their genes promote various sarcomas and because point mutations in FUS or TAF15 can cause neurodegenerative diseases such as amyotrophic lateral sclerosis and frontotemporal lobar dementia. Recent results suggest that both the normal and pathological effects of FET proteins are modulated by low-complexity or prion-like domains, which can form higher-order assemblies with novel interaction properties. Herein, we review FET proteins with an emphasis on how the biochemical properties of FET proteins may relate to their biological functions and to pathogenesis.

Indexed as

Active Transport, Cell NucleusAnimalsDNA RepairHumansNeoplasmsNeurodegenerative DiseasesRNA-Binding Protein FUSRNA-Binding ProteinsRNA Processing, Post-TranscriptionalTATA-Binding Protein Associated FactorsTranscription, GeneticRNA-Binding Protein FUSRNA-Binding ProteinsTATA-Binding Protein Associated FactorsEWSR1FUSlow-complexityneurodegenerationRNA-bindingTAF15

Identifiers

PMID25494299
PMCPMC9188303
OpenAlexW2112714817

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.